Cargando…
Effect of Enteral Guanfacine on Dexmedetomidine Use in the ICU
Describe the efficacy and safety of guanfacine for dexmedetomidine weaning in critically ill patients. DESIGN: Retrospective descriptive analysis. SETTING: Six hundred thirteen–bed academic medical center from October 2020 to October 2021. PATIENT/SUBJECTS: All Adult patients on IV dexmedetomidine w...
Autores principales: | Fetters, Megan B., Diep, Calvin, Ran, Ran, Kloosterboer, Amy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632248/ https://www.ncbi.nlm.nih.gov/pubmed/36349291 http://dx.doi.org/10.1097/CCE.0000000000000785 |
Ejemplares similares
-
Effects of alpha 2-adrenoceptor agonists dexmedetomidine and guanfacine on morphine analgesia and tolerance in rats
por: Gursoy, Sinan, et al.
Publicado: (2011) -
Attention deficits following ADEM ameliorated by guanfacine
por: Singh-Curry, Victoria, et al.
Publicado: (2010) -
Respiratory effects of dexmedetomidine in the ICU
por: Hell, J, et al.
Publicado: (2000) -
Guanfacine for the Treatment of Cognitive Disorders: A Century of
Discoveries at Yale
por: Arnsten, Amy F.T., et al.
Publicado: (2012) -
Metabolite profiling of guanfacine in plasma and urine of healthy Japanese subjects after oral administration of guanfacine extended‐release tablets
por: Inoue, Yuji, et al.
Publicado: (2019)